Japan Association for Diabetes Education and Care Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2010
NCT01183104
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

glimepiride (amaryl) (1 trial)

sitagliptin (januvia) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2